We Need Your Personal Letters for Congress
February 6th and 7th, NF Midwest staff and volunteers will be meeting with our the offices of our Senators and…
Read More
February 6th and 7th, NF Midwest staff and volunteers will be meeting with our the offices of our Senators and…
Read More
An article by Sharon Reynolds from the National Cancer Institue highlights the importance of people with neurofibromatosis type 1(NF1) to…
Read More
Thanks to the support of our donors, NF Midwest is proud to be one of four NF organizations collaborating to…
Read More
We did it! We’re pleased to announce that $20 million in federal funding has been secured for the Neurofibromatosis Research…
Read More
NF Midwest, NF Northeast and NF2 BioSolutions have joined forces to fund an NF2 Gene Therapy Research Study at the…
Read More
An interesting article was just published in the Journal of Paediatric and Child Health called “Perceived fatigue in children and…
Read More
Great News! The signing of the FY20 Defense Appropriations Act by the President today included $15 million in federal funding for the…
Read MoreBig news just hit…though it has been expected! Many of us have been following the success of the drug selumetinib…
Read More
Frank Buono PhD, from the Department of Psychiatry at Yale School of Medicine and longtime member and supporter of NF…
Read More
If you’ve been paying any attention to NF research in the last several years you’ll have noticed that in clinical…
Read More
© 2026 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.